This randomized controlled trial (RCT) is the product of a unique team of organizations that are partnering to address the issue of vaccine hesitancy in Washington State; partners include WithinReach, the Washington State Department of Health, Seattle Children’s Hospital, the Group Health Foundation, and the Community Pediatric Foundation of Washington. Funding in the amount of $1.5 million for the RCT comes primarily from the Group Health Foundation and a one-time family grant from the Bill & Melinda Gates Foundation. Seattle Children’s Hospital, WithinReach, the Community Pediatric Foundation of Washington, and the Department of Health continue to contribute resources, expertise, and guidance to the process.
This approach is the product of several years of preliminary research to identify the best mechanism to address vaccine hesitancy. What sets this intervention apart is the emphasis on testing for efficacy. We believe our intervention is a strong one, but we aim to demonstrate efficacy through this rigorous RCT.
Members of the Vax Northwest Team (from left to right): Todd Faubion, WithinReach; Nora Henrikson, Group Health Research Institute; Janna Bardi, Department of Health; Tizzy Bennett, Seattle Children's Hospital; Patty Hayes, WithinReach; Ginny Heller, WithinReach; Joe Turcotte, Group Health Foundation; Michele Roberts, Department of Health; Ed Marcuse, Seattle Children's Hospital; Kris Hildebrandt, Group Health Foundation